Evidence map›Paper›PMID 39280542›Full record

ReviewCureus2024

Assessing the Impact of Hematological Changes in Pregnancy on Maternal and Fetal Death: A Narrative Review.

Mayuri N Paradkar, Idalia Mejia, Rasha Abraheem, Esaúl Marroquín León, Afreen Firdous, Maria Jimena Barroso, Dexith Kumar Sampathkumar, Zoya Morani

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Efficacy and safety of Ashwagandha (Frontiers in global women's health · 2026
    Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Coagulation indices for predicting hypertensive pregnancy disorders.American journal of translational research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mayuri N ParadkarDepartment of Geriatrics and General Medicine, Blackpool Victoria Hospital, Blackpool Teaching Hospitals and NHS Foundation Trust, Blackpool, GBR.
Idalia MejiaDepartment of Medicine, Universidad Católica de Honduras, San Pedro Sula, HND.
Rasha AbraheemDepartment of Obstetrics and Gynecology, Benghazi Medical Hospital, Benghazi Medical University, Benghazi, LBY.
Esaúl Marroquín LeónDepartment of Medicine, Facultad de Medicina de la UW, Santa Fe, MEX.
Afreen FirdousDepartment of Medicine and Surgery, Shadan Institute of Medical Sciences, Hyderabad, IND.
Maria Jimena BarrosoDepartment of Internal Medicine, Universidad Anáhuac México, Mexico City, MEX.
Dexith Kumar SampathkumarDepartment of Medicine, University of Perpetual Help System, Las Pinas, PHL.
Zoya MoraniDepartment of Family Medicine, Ascension All Saints - Family Health Center, Milwaukee, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematological changes during pregnancy encompass a wide range of alterations in blood composition and function, including variations in hemoglobin levels, red blood cell count, and coagulation factors. These changes can be physiological or pathological and may significantly impact maternal and fetal health outcomes. This narrative review examines the relationship between various hematological changes and disorders during pregnancy and their effects on maternal and fetal mortality and morbidity. We explore conditions such as anemia, sickle cell disease, thrombophilia, and blood-borne infections like malaria, as well as the impact of multiple pregnancies on hematological parameters. The review also discusses the effects of COVID-19 on maternal hematology. Key findings include the high prevalence of adverse perinatal outcomes associated with these conditions, including early miscarriages, preterm birth, low birth weight, intrauterine growth restriction, and increased risk of maternal complications. The importance of early screening, diagnosis, and appropriate management of hematological disorders during pregnancy is emphasized. This review highlights the need for a multidisciplinary approach to managing pregnant women with hematological changes to optimize maternal and fetal outcomes.

Indexed as

anemia in pregnancyfetal mortalityhematological changes in pregnancymaternal mortalityperipartum physiological changesthrombophilia in pregnancytwin gestation

Identifiers

PMID39280542
PMCPMC11402273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.